Cognitive impairment in PD associated with LRRK2 mutations is the most studied NMS, and existing evidence suggests that dementia is uncommon in these patients even one or two decades after the onset of the disease. The gene discussed is LRRK2; the disease is neuroleptic malignant syndrome.